NR3C1 and inflammatory bowel disease: We demonstrate that the immunosuppressive action of intestinal epithelial GR signaling ameliorated IBD but promoted chronic inflammation–induced colorectal cancer through suppression of macrophage-mediated tissue repair and antitumor responses.